26
Views
0
CrossRef citations to date
0
Altmetric
PHARMACOTHERAPY

Trends in antipsychotic prescribing practices in an urban community mental health clinic

, , , &
Pages 238-241 | Published online: 20 May 2010
 

Abstract

Objective: Availability of new psychotropic agents, and formulations, as well as expanded indications for previously available agents, has had an impact on prescribing patterns in community psychiatric practice. This study tracked changes in patient diagnostic profiles and compared antipsychotic prescribing patterns for patients managed by a continuing care team over a 2.25-year period.

Method: Data pertaining to patient diagnoses and psychotropic medications was obtained from sequential cross-sectional file review and the pharmacy database. Data were collected in late 2004 (n = 224) and early 2007 (n = 294).

Results: The majority of patients suffered from DSM-IV schizophrenia, schizoaffective and related disorders (68% in 2004, 71% in 2007). Second generation antipsychotic (SGA) medications (79% in 2004, 99% in 2007 of all antipsychotics) were the most widely used agents. Use of quetiapine as a proportion of all oral SGAs increased (8% to 17%) as did that of long-acting risperidone (<1% to 17% of all antipsychotics) paralleled by a decline in long-acting first generation antipsychotic agents (15% to <1%). Significant changes in the prescription of non-benzodiazepine hypnotics and mood stabilizers were also noted.

Conclusions: Statistically significant changes in prescribing patterns of antipsychotics during the study period were noted. Likely causes are discussed.

DISCLOSURE

KM, JO, BC, PB have no declaration of interest to declare. DC has received research grants, travel support and honoraria for talks or served on advisory boards of: Janssen-Cilag, Roche, Allergen, Organon, Sanofi-Aventis, Lundbeck, Eli Lilly, Bristol-Myers Squibb, Astra-Zeneca, Wyeth, Pfizer, and Schering-Plough.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.